A pharma giant that has become synonymous with job cuts and prioritising shareholders over public health.

Check all our investigations on Sanofi.

Tous les chiffres


  • N° 8 of the pharma industry globally
  • 1st of the pharma industry in France
  • N° 3 for vaccines globally

Profits and dividends (million €)

Greenhouse gas emissions declared (2021, thousand tons eqCO2)


CEO pay

10,98 million € (2021)

Pay ratio between CEO and average worker

112 (2021)


47,7 % of employees 18,2 % of executive committee (2021)

Lobbying expenses declared

6,6 -7.1 million € (Paris, Brussels and Washington, 2021)

Share of subsidiaries in secret jurisdictions

18,3 % (2019)


22,7 % of turnover (2021)
  • Website
  • Headquarters 54 rue La Boétie, Paris
  • Leadership Paul Hudson (CEO since 2019), Serge Weinberg (chairman of the board since 2010)
  • Shareholders L’Oréal (9,36%), BlackRock (6,99%)
  • Board members Serge Weinberg (chairman of the board, ex Kering), Paul Hudson (CEO, ex AstraZeneca and Novartis), Christophe Babule (L’Oréal), Rachel Duan (administrator of companies, ex GE), Carole Ferrand (Capgemini), Lise Kingo (administrator of companies, ex Global Compact), Patrick Kron (Imerys, ex Alstom), Wolfgang Laux (workers representative), Barbara Lavernos (L’Oréal), Fabienne Lecorvaisier (Air Liquide), Gilles Schnepp (Danone, Legrand, Saint-Gobain), Diane Souza (ex Aetna and UnitedHealth), Thomas Südhof (Professor, Stanford), Yann Tran (workers representative), Emile Voest (oncologist, Cancer Core Europe), Antoine Yver (Centessa Pharmaceuticals).
  • Key subsidiaries Sanofi Pasteur, Genzyme
  • Former names and companies absorbed Sanofi-Aventis, Aventis, Hoechst, Rhône-Poulenc, Synthélabo
  • Main countries France, United States, Japan, Canada, United Kingdom, Italy, Germany

Sanofi in our investigations

Latest articles on Sanofi

Get in touch with us

  • Need more information?
  • Have a question?
  • Or an information to share?
Contact us